ArticleMedicine2020

A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy.

Dongmei Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.